Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
OMNIPAQUE 300 GE HEALTHCARE CANADA INC Resolved 647MG Updated Report 2024-02-24 217417
VISIPAQUE 320 GE HEALTHCARE CANADA INC Resolved 652MG Updated Report 2024-02-24 217420
DETROL BGP PHARMA ULC Actual shortage 1MG Updated Report 2024-02-24 219750
APO-ABIRATERONE FILM COATED TABLETS APOTEX INC Actual shortage 250MG New Report 2024-02-23 220474
APO-ABIRATERONE FILM COATED TABLETS APOTEX INC Actual shortage 250MG New Report 2024-02-23 220471
APO-TRYPTOPHAN APOTEX INC Actual shortage 1G New Report 2024-02-23 220468
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS APOTEX INC Actual shortage 100MG Updated Report 2024-02-23 220465
APO-SIMVASTATIN APOTEX INC Actual shortage 40MG New Report 2024-02-23 220462
APO-DOXYLAMINE/B6 APOTEX INC Actual shortage 10MG 10MG Updated Report 2024-02-23 220459
APO-MONTELUKAST APOTEX INC Actual shortage 10MG Updated Report 2024-02-23 220456

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PROCTOSEDYL APTALIS PHARMA CANADA ULC To be discontinued 1% 1% 0.5% 0.5% New Report 2024-02-23 220351
!!T3 LODALIS BAUSCH HEALTH, CANADA INC. Discontinued 3.75G New Report 2024-02-20 212799
!!T3 FLOMAX CR BOEHRINGER INGELHEIM (CANADA) LTD LTEE Discontinued 0.4MG Updated Report 2024-02-17 213714
DULOXETINE SANIS HEALTH INC To be discontinued 60MG Updated Report 2024-02-15 219591
DULOXETINE SANIS HEALTH INC To be discontinued 30MG New Report 2024-02-15 219618
INTEGRILIN MERCK CANADA INC Discontinued 0.75MG Updated Report 2024-02-14 155790
INTEGRILIN MERCK CANADA INC Discontinued 2MG Updated Report 2024-02-14 155794
FRAGMIN PFIZER CANADA ULC Discontinued 10000UNIT Updated Report 2024-02-14 196174
NIFEDIPINE ER PRO DOC LIMITEE Discontinued 30MG New Report 2024-02-12 219232
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.05% Updated Report 2024-02-08 217843